Class 1. Pulmonary Hypertension Associated with Inflammation

Chronic Inflammation as the Underlying Mechanism of the Development of Lung Diseases in Psoriasis: A Systematic Review

Mateusz Mleczko, Agnieszka Gerkowicz, Dorata KrasowskaMedical University of LublinPoland International Journal of Molecular ScienceInt J Mol Sci 2022; 23: DOI: 10.3390/ijms23031767 AbstractPsoriasis is a systemic inflammatory disease caused by dysfunctional interactions between the innate and adaptive immune responses. The systemic inflammation in psoriasis may be associated with the development of comorbidities, including lung diseases. In this […]

Chronic Inflammation as the Underlying Mechanism of the Development of Lung Diseases in Psoriasis: A Systematic Review Read More »

Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation

Emmanouil Mavrogiannis, Quint A. J. Hagdorn, Venetia Bazioti, Johannes M. Douwes, Diederik E. Van Der Feen, Silke U. Oberdorf‐Maass, Marit Westerterp, Rolf M. F. BergerBeatrix Children’s Hospital, University Medical Center Groningen and University of GroningenNetherlands Pulmonary CirculationPulm Circ 2022; 12: DOI: 10.1002/pul2.12101 AbstractPulmonary arterial hypertension (PAH) is a fatal disease characterized by increased pulmonary arterial pressure,

Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation Read More »

Scroll to Top